...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: $3,000 USD cost to present....

That's as per Biopharm America on their website....well, $2,995 USD, I added $5 and rounded up....so around $3,700 CDN.  


Of course beyond that cost there's obviously transportation, meals and accomodation as well as any sundry expenses.  I doubt Kenneth would be staying at the Y....probably over $5,000.  

And given recent history I think it wise to check on what the costs would be to cancel....

Upon cancellation of a presentation slot the full presentation fee is applicable and not refundable.

In any case if the company has to cancel for a scheduling conflict, or any other reason...I expect timely and transparent communication of that fact.  Hopefully that's a moot point and we get to hear what the company has to say.  

New Message
Please login to post a reply